Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis

Diabetic kidney disease is the leading cause of end-stage kidney disease in high-income countries. The strict control of glycemic oscillations is the principal therapeutic target, but this could be hard to achieve in uremic patients due to their unpredictable insulin sensitivity. Currently, the eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallieni, Maurizio, De Salvo, Cristina, Lunati, Maria Elena, Rossi, Antonio, D’Addio, Francesca, Pastore, Ida, Sabiu, Gianmarco, Miglio, Roberta, Zuccotti, Gian Vincenzo, Fiorina, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272699/
https://www.ncbi.nlm.nih.gov/pubmed/33743082
http://dx.doi.org/10.1007/s00592-021-01699-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272699/
https://www.ncbi.nlm.nih.gov/pubmed/33743082
http://dx.doi.org/10.1007/s00592-021-01699-6

Ejemplares similares